- Multimedia -

2008 Consensus Conference on the Safety of Intravenous Drug Delivery Systems

Program Description The highlights and outcomes of the 2008 Consensus Conference on the Safety of IV Drug Delivery Systems has been captured and developed into a multi-media continuing education program. The purpose of this conference was to evaluate the safety of IV infusion systems used for medication administration building on the work from the initial Consensus Conference that convened in 1999. The Second Consensus Conference expanded on the initial conference findings through presentations regarding the impact of medication errors, a review of related standards and guidelines released since 1999, and analyses and perspectives on different IV drug delivery systems.

Learning Objectives

Upon completion of this activity, pharmacists, nurses and physicians will be able to:

• Describe the current state of  IV drug delivery in US health systems

• Discuss analyses and perspectives on the issues surrounding available IV drug delivery systems

• Describe the current regulatory environment regarding IV drug delivery

• Outline specific safety considerations that affect the utility of IV drug delivery systems

Program Faculty

Michael D. Sanborn, MS, RPh, FASHP
Vice President, Cardiology Services
Baylor Health Care System

Jeannell M. Mansur, RPh, PharmD, FASHP
Practice Leader, Medication Safety
Joint Commission Resources, Inc.

E. Clyde Buchanan, MS, FASHP
Healthcare Consultant

Marty Kochevar, MS, RPh, BCNSP
Clinical Practice Consultant
American Society for Parenteral and Enteral Nutrition

Rita Shane, PharmD, FASHP, FCSHP
Director of Pharmacy Services
Cedars-Sinai Medical Center
Assistant Dean of Clinical Pharmacy Services
University of California, San Francisco

Disclosure

It is the policy of ProCE, Inc. to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Mr. Sanborn, Dr. Mansur, Mr. Buchanan, Mr. Kochevar, and Dr. Shane have reported that they have no significant financial or commercial relationships to disclose.

Please note: The information and views presented in this CE activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may include the use of drugs and/or devices for unlabeled indications. Use of drugs and/or devices outside of labeling should be considered experimental. Participants are advised to consult and verify manufacturer product information, the professional literature and use his/her professional judgment in applying the presented information in patient care activities.

CE Accreditation

Pharmacists:
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Program Number 221-000-09-011-H05-P has been assigned to this home study, knowledge-based activity. This program is acceptable for 2.0 contact hours (0.20 CEUs) in states that recognize ACPE providers.

Physicians:
This activity has been planned and implemented in accordance with the essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of ProCE, Inc. and the National Association of Managed Care Physicians (NAMCP). The NAMCP is accredited by the ACCME to provide continuing medical education (CME) to physicians. The NAMCP designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits�. Physicians should only claim credit commensurate with the extent of their participation in the activity. Expires 02/14/2012

Nurses:
Wild Iris Medical Education, WSNA CEARP Provider number PA-5/Feb/11, is an approved provider of continuing education by the Washington State Nurses Association, an accredited approver by the American Nurses' Credentialing Center�s Commission on Accreditation. California Board of Registered Nursing Provider #12300. This activity provides 2.0 contact hours of nurse CE credit.

Release Date: 02-14-2009
Expiration Date: 02-14-2012

Funding

This program is supported by an educational grant from Baxter Healthcare Corporation.